PhotoBiotics : Targeting Photodynamic therapy PhotoBiotics in the News »  
PhotoBiotics : Targeting Photodynamic therapy
PhotoBiotics : Targeting Photodynamic therapy

Home > PhotoBiotics Team > Dr Elizabeth Rollinson

Dr Elizabeth Rollinson

Dr Elizabeth Rollinson (Non-Executive Director) joined the Board in April 2006, primarily to provide strategic business development direction to the company. She was previously the Commercial Director for Xenova Group plc, a leading dual-listed UK-based biotech company and concurrently served as Managing Director for Phogen, and as a Non-Executive Director of Discerna. Liz has over 25 years experience in the pharmaceutical industry, and in addition to closing a number of significant commercial transactions for Cantab and Xenova, she has extensive experience of managing the whole R&D spectrum, including manufacturing, and is a registered Qualified Person. Liz has spent the last 12 years in the commercial arena, being involved in business development, IP, licensing, M&A, and fund-raising. She obtained her PhD from Imperial College.

Liz brings a strong commercial focus to the PhotoBiotics team

Back

 

   
Background Technology Markets Finance Strategic Development The PhotoBiotics Team Contact Us About Us ::  Design by Get Online Design  ::